USCWA
RETA

U.S. Capital Wealth Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed -$11.4K – 1599
2022
Q4 		$11.4K Buy
+300
New +$11.4K ﹤0.01% 1245